Seaport Research raised the firm’s price target on Hims & Hers to $26 from $24 and keeps a Buy rating on the shares. The firm increased its price target on the stock due to the launch of GLP-1 and the increased likeliness in the firm’s view for continued upside, the analyst tells investors. Hims & Hers’ has “strong brands” in telehealth and is well positioned to gain share among compounded GLP-1 offerings, the firm adds.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on HIMS: